Andy Burnham says he is welcoming a world-first dementia drug trial, the AD-SMART Alzheimer’s study, after his father Roy died from the disease. Reporting across outlets describes the trial as aimed at speeding up the development and potential NHS availability of treatments that could tackle dementia.
The Mirror frames the story around Burnham’s personal motivation and the prospect of earlier access to first dementia drugs. Mail Online and the Daily Mail emphasise that “hundreds” of Alzheimer’s patients will take part and that the trial tests whether ADHD drugs could help address dementia symptoms, citing studies that suggest potential benefits. While their headlines differ slightly in phrasing and focus, both outlets also foreground Burnham’s role and the timing of his father’s death as context for his support.
